Pfizer says Covid-19 pills cut hospital, death risk by 90%

Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Currently most COVID-19 treatments require an IV or injection. Competitor Merck’s COVID-19 pill is already under review atContinue reading “Pfizer says Covid-19 pills cut hospital, death risk by 90%”

J&J, Moderna COVID boosters began last Friday

[the_ad id=”576″] A second dose of the J&J vaccine was recommended for everyone who received their first dose at least two months ago. Last Thursday night, The director of the Centers for Disease Control and Prevention signed off on mix-and-match COVID-19 booster shots The committee said it could increase protection against the disease that is killing on averageContinue reading “J&J, Moderna COVID boosters began last Friday”